‘I couldn’t care less’: Postecoglou bats away speculation before Frankfurt trip
Nvidia expects to take $5.5bn hit as US tightens AI chip export rules to China
In the red: global wine sales fall to lowest levels since 1961
China accuses UK politicians of ‘arrogance’ in British Steel row
Revealed: Big tech’s new datacentres will take water from the world’s driest areas
‘I couldn’t care less’: Postecoglou bats away speculation before Frankfurt trip
Nvidia expects to take $5.5bn hit as US tightens AI chip export rules to China
In the red: global wine sales fall to lowest levels since 1961
China accuses UK politicians of ‘arrogance’ in British Steel row
Revealed: Big tech’s new datacentres will take water from the world’s driest areas
Dostarlimab or Jemperli, an immunotherapy used alongside chemotherapy, could extend life expectancy
A drug that could improve the quality of life of hundreds of women with womb cancer will be rolled out on the NHS across England from Tuesday.
Dostarlimab, also known as Jemperli, is an immunotherapy that works by attracting specific proteins on the surface of cancer cells to help the immune system attack them.
Notifications
More Stories
Revealed: Chinese researchers can access half a million UK GP records
Brisk walking linked to lower risk of heart rhythm problems, study finds
RFK Jr contradicts experts by linking autism rise to ‘environmental toxins’